OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MIDAN.KW55

Al-Maidan Clinic for Oral Health Services Company KSCP

Healthcare Facilities & ServicesVerified

The company maintains a strong liquidity position, with a current ratio of 2.7, indicating that it has 2.7 times more current assets than current liabilities. Its cash and equivalents amount to KWD 44.85 million, which is a significant portion of its total assets of KWD 127.66 million. The company's debt-to-equity ratio is 0.02, suggesting a low reliance on debt financing and a strong equity base. In terms of profitability, the company's return on equity (ROE) is 10.5%, and its return on assets (ROA) is 7.26%. These figures are strong indicators of efficient use of equity and assets to generate profits. The operating income of KWD 13.91 million and net income of KWD 9.27 million reflect a healthy margin, with a gross profit of KWD 25.42 million. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no indication of geographic diversification, with all operations presumably based in Kuwait. This concentration may pose a risk if the local market experiences economic downturns or regulatory changes. The company's growth trajectory is not explicitly detailed in the available data, but its consistent revenue and profit figures suggest stable operations. The capital expenditure of KWD -1.52 million indicates a reduction in investment in physical assets, which may be a strategic decision to preserve cash. The free cash flow of KWD 8.63 million and operating cash flow of KWD 10.49 million support the company's ability to fund operations and potentially invest in growth opportunities. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves further support this assessment. There is no evidence of dilution potential in the basic shares outstanding, which remain at 202.5 million. Recent events, as reflected in the financial data, show a stable financial performance with no significant changes in the company's operations or financial structure. The company's financial statements do not indicate any recent major events that would significantly impact its operations or financial health.

30-day price · MIDAN.KW-5.00 (-0.6%)
Low$784.00High$825.00Close$820.00As of25 May, 00:00 UTC
Profile
CompanyAl-Maidan Clinic for Oral Health Services Company KSCP
TickerMIDAN.KW
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Al-Maidan Clinic for Oral Health Services Company KSCP provides dental care services in Kuwait, generating revenue primarily through patient consultations and treatments.

Classification. The company is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

The company maintains a strong liquidity position, with a current ratio of 2.7, indicating that it has 2.7 times more current assets than current liabilities. Its cash and equivalents amount to KWD 44.85 million, which is a significant portion of its total assets of KWD 127.66 million. The company's debt-to-equity ratio is 0.02, suggesting a low reliance on debt financing and a strong equity base. In terms of profitability, the company's return on equity (ROE) is 10.5%, and its return on assets (ROA) is 7.26%. These figures are strong indicators of efficient use of equity and assets to generate profits. The operating income of KWD 13.91 million and net income of KWD 9.27 million reflect a healthy margin, with a gross profit of KWD 25.42 million. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements. There is no indication of geographic diversification, with all operations presumably based in Kuwait. This concentration may pose a risk if the local market experiences economic downturns or regulatory changes. The company's growth trajectory is not explicitly detailed in the available data, but its consistent revenue and profit figures suggest stable operations. The capital expenditure of KWD -1.52 million indicates a reduction in investment in physical assets, which may be a strategic decision to preserve cash. The free cash flow of KWD 8.63 million and operating cash flow of KWD 10.49 million support the company's ability to fund operations and potentially invest in growth opportunities. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and strong cash reserves further support this assessment. There is no evidence of dilution potential in the basic shares outstanding, which remain at 202.5 million. Recent events, as reflected in the financial data, show a stable financial performance with no significant changes in the company's operations or financial structure. The company's financial statements do not indicate any recent major events that would significantly impact its operations or financial health.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 2.7 and significant cash reserves.
  • Profitability metrics such as ROE and ROA are strong, indicating efficient use of equity and assets.
  • The company's revenue is concentrated in a single segment and geographic location, which may pose a risk.
  • The company has low liquidity and dilution risks, with no immediate filing-based flags detected.
  • The company's capital expenditure is negative, suggesting a reduction in investment in physical assets.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKWD
Revenue$72.0M
Gross profit$25.4M
Operating income$13.9M
Net income$9.3M
R&D
SG&A
D&A
SBC
Operating cash flow$10.5M
CapEx-$1.5M
Free cash flow$8.6M
Total assets$127.7M
Total liabilities$39.4M
Total equity$88.2M
Cash & equivalents$44.9M
Long-term debt$1.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$88.2M
Net cash$43.1M
Current ratio2.7
Debt/Equity0.0
ROA7.3%
ROE10.5%
Cash conversion1.1%
CapEx/Revenue-2.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 779 companies
MetricMIDAN.KWActivity
Op margin19.3%7.7% medp25 -2.4% · p75 15.5%top quartile
Net margin12.9%5.9% medp25 -3.8% · p75 12.8%top quartile
Gross margin35.3%45.5% medp25 31.1% · p75 62.9%below median
R&D / revenue529.2% medp25 465.2% · p75 593.2%
CapEx / revenue-2.1%-7.0% medp25 -14.9% · p75 -3.2%top quartile
Debt / equity2.0%25.0% medp25 3.8% · p75 63.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-22 11:30 UTC#de826483
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 14:01 UTCJob: 0c28fe0a